Cardiology
Europe: the EU Cardiovascular Health Plan is becoming the “cancer plan” moment for heart disease
The EU’s Safe Hearts Plan is moving into implementation, opening a debate about cardiovascular screening, prevention and personalised care across Europe. The question now is whether Europe can replicate for heart disease what it achieved with its Beating Cancer Plan.
A new Lp(a) threshold could reshape cardiovascular risk assessment
AlphaGenome Makes Variant Interpretation Political
AI Diagnosis Has Entered the Access Debate
Africa’s Cardiovascular Decade Is a System-Design Problem
Inherited Lipid Screening Becomes Europe’s Prevention Test
ATTR Gene Editing Restarts, But Safety Becomes the Access Question
Routine CT Scans Could Become a Heart Failure Early-Warning System
Risk Prediction Cannot Simply Be Imported From Europe
Personalised Cardiology Needs a Digital Fabric, Not Just More Data
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.